Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Sanofi”

Anti-PD1-antibody and Pulsed HHI for Advanced BCCUnknown
NCT04679480Phase 2Updated Jul 30, 2024
Sponsor: Reinhard Dummer
Basal Cell Carcinoma
Switzerland
Real Life Lipid Management in Hospitals Not Participating in PENELOPE Trial - Control Population for PENELOPECompleted
NCT05659888N/AUpdated Jul 26, 2024
Sponsor: Clinical Operations WCN B.V.
Atherosclerotic Cardiovascular Disease · STEMI · Non STEMI
Netherlands
Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid CancerCompleted
NCT01876784Phase 3Updated Jul 23, 2024
Sponsor: Genzyme, a Sanofi Company
Differentiated Thyroid Cancer
United States, Brazil, China, Czechia, Denmark +7 more
Molecular Imaging in Fabry Disease of the HeartUnknown
NCT06226987N/AUpdated Jul 22, 2024
Sponsor: University of Cambridge
Fabry Disease, Cardiac Variant
United Kingdom
Screening Program for Type 1 Diabetes in a High-Risk PopulationRecruiting
NCT06513247N/AUpdated Jul 22, 2024
Sponsor: King Saud University
Type 1 Diabetes
Saudi Arabia
Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive AdultsCompleted
NCT02741128Phase 2Updated Jul 19, 2024
Sponsor: Sanofi Pasteur, a Sanofi Company
Dengue Fever · Dengue Hemorrhagic Fever · Human Immunodeficiency Virus
Brazil
A Study in Male and Female Adult Patients With Atopic Dermatitis Treated With Dupilumab in TaiwanCompleted
NCT05442645N/AUpdated Jul 18, 2024
Sponsor: Sanofi
Atopic Dermatitis
China
A Study in Male and Female Adult Participants With Chronic Rhinosinusitis With Nasal Polyps In the Greater Gulf RegionCompleted
NCT05649813N/AUpdated Jul 11, 2024
Sponsor: Sanofi
Chronic Rhinosinusitis With Nasal Polyps
Kuwait
MRI Assessment of Mode of Action of Bisacodyl, Multiple DosesCompleted
NCT04129788Phase 4Updated Jul 3, 2024
Sponsor: University of Nottingham
Constipation
United Kingdom
A Long-Term Study of Olipudase Alfa in Patients With Acid Sphingomyelinase DeficiencyCompleted
NCT02004704Phase 2Updated Jul 3, 2024
Sponsor: Genzyme, a Sanofi Company
Sphingomyelin Lipidosis
United States, Belgium, Brazil, France, Germany +2 more
MRI Assessment of Mode of Action of Bisacodyl, Single DoseCompleted
NCT04132661Phase 4Updated Jul 3, 2024
Sponsor: University of Nottingham
Constipation
United Kingdom
A Study on the Timing of FOLFOX for Patients With Operable, Node Positive Rectal CancerCompleted
NCT01274962Phase 2Updated Jun 26, 2024
Sponsor: Sir Mortimer B. Davis - Jewish General Hospital
Operable T2-3N+M0 Rectal Cancer (Stage III)
Canada
Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and ToddlersCompleted
NCT03691610Phase 3Updated Jun 25, 2024
Sponsor: Sanofi Pasteur, a Sanofi Company
Healthy Volunteers (Meningococcal Infection)
United States, Puerto Rico
Phenotyping Responses to Systemic Corticosteroids in the Management of Asthma AttacksCompleted
NCT05870215N/AUpdated Jun 21, 2024
Sponsor: Université de Sherbrooke
Asthma
Canada
Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) PatientsCompleted
NCT03194867Phase 1, Phase 2Updated Jun 14, 2024
Sponsor: Sanofi
Plasma Cell Myeloma
United States, Australia, Brazil, Canada, Czechia +5 more
Pharmacokinetics (PK) of Rilzabrutinib (PRN1008) in Healthy Japanese and Caucasian SubjectsCompleted
NCT06444191Phase 1Updated Jun 5, 2024
Sponsor: Principia Biopharma, a Sanofi Company
Healthy Volunteers
United States
An Open-label Extension Study of an Investigational Drug, Fitusiran, in Patients With Moderate or Severe Hemophilia A or BCompleted
NCT02554773Phase 1, Phase 2Updated Jun 5, 2024
Sponsor: Genzyme, a Sanofi Company
Hemophilia A · Hemophilia B
United States, Bulgaria, Russia, Switzerland, United Kingdom
A Study to Evaluate the Effect of Mild and Moderate Hepatic Impairment on the Single-Dose Pharmacokinetics of Rilzabrutinib (PRN1008)Completed
NCT06444204Phase 1Updated Jun 5, 2024
Sponsor: Principia Biopharma, a Sanofi Company
Hepatic Function Abnormal · Healthy Volunteers
United States
A Study of the Safety, Tolerability, and Pharmacokinetics of Orally Administered Venglustat and Itraconazole in Healthy Adult Male ParticipantsCompleted
NCT06421714Phase 1Updated May 20, 2024
Sponsor: Genzyme, a Sanofi Company
Healthy Volunteers
United States
A Study of the Safety, Tolerability, and Bioequivalence of Orally Administered Venglustat in Healthy Adult ParticipantsCompleted
NCT06418607Phase 1Updated May 17, 2024
Sponsor: Sanofi
Healthy Volunteers
United States
A Study of the Safety, Tolerability, and Bioavailability of Orally Administered Venglustat in Healthy Adult ParticipantsCompleted
NCT06418620Phase 1Updated May 17, 2024
Sponsor: Sanofi
Healthy Volunteers
United States
Burden of Respiratory Syncytial Virus (RSV) in Children in Sweden (BRICS): A Retrospective Study in SwedenCompleted
NCT05622331N/AUpdated May 14, 2024
Sponsor: Sanofi Pasteur, a Sanofi Company
Respiratory Syncytial Virus (RSV)
Safety and Imaging Study of GC1008 in GliomaCompleted
NCT01472731Phase 2Updated May 6, 2024
Sponsor: University Medical Center Groningen
Primary Brain Tumors
Netherlands
Efficacy and Safety of Vandetanib (ZD6474) in Patients With Metastatic Papillary or Follicular Thyroid CancerCompleted
NCT00537095Phase 2Updated Apr 19, 2024
Sponsor: Genzyme, a Sanofi Company
Thyroid Neoplasms
Belgium, Denmark, France, Norway, Spain +2 more
Digital Health Platform Customized for Patients With Gaucher DiseaseCompleted
NCT04997772N/AUpdated Apr 17, 2024
Sponsor: Shoshana Vilk
Gaucher Disease · Patient Reported Outcome
Israel

Previous page Next page